Dalfampridine 10 mg Tablets contain dalfampridine, also known as fampridine or 4-aminopyridine. The 10 mg extended-release formulation is used to improve walking in adults with multiple sclerosis (MS). Product specifications, brand names, and approved indications may vary by market.
Dalfampridine 10 mg Extended-Release Tablets are used to improve walking in adults with multiple sclerosis. Fampridine is another name for the active ingredient, and the medicine works by blocking certain potassium channels, which may improve the conduction of electrical signals along nerves affected by MS.
The extended-release formulation is important. Immediate-release 4-aminopyridine products should not automatically be treated as interchangeable with approved dalfampridine or fampridine extended-release tablets.
Use the official prescribing information for the exact product when describing dosage, administration, contraindications, warnings, and approved indications.
Dalfampridine and fampridine are names used for the same active substance in different markets. Ampyra is a recognized US brand, while Fampyra is marketed in Europe and other markets. Dalstep is a brand name associated with dalfampridine 10 mg tablets in certain markets.
The name “fampiridine” may appear as a misspelling or search variant of “fampridine.” Include it naturally where useful for search relevance, but use the correct active ingredient name in the main product content.
Use brand-specific names only when the actual product being sold matches that brand and packaging. Do not imply that every dalfampridine product is Ampyra, Fampyra, or Dalstep.
Compare the verified product details, strength, formulation, pack size, and price before placing an order. Confirm the applicable prescription requirements and whether the specific product can legally be supplied in the destination country.
Suggested product button: Buy Dalfampridine 10 mg Tablets
Dalfampridine extended-release tablets are used to improve walking in adults with multiple sclerosis. The exact indication should follow the applicable product label.
Dalfampridine and fampridine are names for the same active substance. Naming conventions vary by market.
Ampyra and Fampyra are brand names associated with dalfampridine or fampridine 10 mg extended-release tablets in specific markets. Confirm the manufacturer, formulation, and packaging before identifying a product by either brand name.
4-Aminopyridine is another chemical name for the active substance. However, immediate-release formulations and approved extended-release tablets may differ in formulation, dosing, safety, and regulatory status. They should not be assumed to be interchangeable.
Dalfampridine is the active ingredient, while Dalstep is a brand name associated with a 10 mg dalfampridine tablet product in certain markets. Check the actual product label to confirm the manufacturer and formulation.
The price depends on the brand, manufacturer, pack size, pharmacy, and country. Display the verified current price for the exact product offered.
Online purchase depends on local regulations, prescription requirements, and whether the seller is authorized to supply the medicine. Confirm these requirements before ordering.
Many established 10 mg dalfampridine products are extended-release tablets. Verify the formulation on the specific product packaging and official prescribing information before publishing this claim for an individual product.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.